Skip to main content
SpringerLink
Log in

Sister chromatid exchanges in peripheral lymphocytes of urinary tract infection treated with nitrofurantoin

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Nitrofurantoin, a widely used antibacterial agent in the therapy of urinary tract infections of bacterial origin, has been widely discussed in recent years due to its genotoxicity. Sister chromatid exchanges (SCE) were studied in lymphoycte cultures of 15 urinary tract infection patients before and after medication with daily oral doses of 10 mg/kg or 400 mg nitrofurantoin for 10 days. Both stages exhibited similar average numbers of SCE in circulating lymphocytes. The number of SCE was larger in smokers. The results of this study suggest that the short-term exposure to nitrofurantoin does not cause detectable cytogenetic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andriole, V. T.: Urinary tract agents: quinolones, nitrofurantoin and methamine. In: Mandell, G. L., Douglas, R. G. Jr., Bennett, J. E. (eds): Principles and Practice of Infectious Diseases. John Wiley and Sons, New York 1985, p. 244.

    Google Scholar 

  2. Bala Krishna, M. P.: Frequency of SCE in cigarette smokers.Hum. Genet., 52, 343 (1979).

    Article  Google Scholar 

  3. Chamberlain, R. E.: Chemotherapeutic properties of prominent nitrofurans.J. Antimicrob. Chemother., 2, 325 (1976).

    Article  PubMed  CAS  Google Scholar 

  4. Chessin, H., McLauchin, Z., Mroczkowski, W. D., Low, K. B.: Radiosensitisation mutagenicity and toxicity of E. coli by several nitrofurans and nitroimidazoles.Radiat. Res., 75, 423 (1978).

    Article  Google Scholar 

  5. Cunha, B. A.: Nitrofurantoin—current concepts.Urology, 32, 67 (1988).

    Article  PubMed  CAS  Google Scholar 

  6. Das, B. C.: Factors that influence formation of Sister Chromatid Exchanges in human blood lymphocytes.CRC Crit. Rev. Toxicol., 19, 43 (1988).

    CAS  Google Scholar 

  7. Food and Drug Administration: Furazolidone (NF-180).Fed. Reg., 49, 34971 (1984).

    Google Scholar 

  8. Klemencic, J. M., Wang, C. Y.: Mutagenicity of nitrofurans. In: G. T. Brayan (ed.): Carcinogenesis. Vol. 4, Nitrofurans: Chemistry, Metabolism, Mutagenesis and Carcinogenesis. Raven Press, New York 1978, p. 99.

    Google Scholar 

  9. Maranpot, R. R.: Ovarian toxicity and carcinogenicity in eight recent National Toxicology Program studies.Environ Health Perspect., 73, 125 (1987).

    Google Scholar 

  10. McCalla, D. R., Voutsinos, D.: On the mutagenicity of nitrofurans.Mutation Res., 26, 3 (1974).

    PubMed  CAS  Google Scholar 

  11. McCalla, D. R., Olive, P. L., Tu, Y., Fan, M. L.: Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivo.Can. J. Microbiol., 21, 1484 (1975).

    Article  PubMed  CAS  Google Scholar 

  12. McCalla, D. R., Voutsinos, D., Olive, P. L.: Mutagen screening with bacteria: nitridazole and nitrofurants.Mutation Res., 31, 31 (1975).

    PubMed  CAS  Google Scholar 

  13. Mohindra, J. K., Rauth, A. M.: Increased cell killing by metronidazole and nitrofurazone of hypoxic cell compared to aerobic mammalian cells.Cancer Res., 36, 930 (1976).

    PubMed  CAS  Google Scholar 

  14. Olive, P. L., McCalla, D. R.: Damage to mammalian cell DNA by nitrofurans.Cancer Res., 35, 781 (1975).

    PubMed  CAS  Google Scholar 

  15. Olive, P. L., McCalla, D. R.: Cytotoxigenicity and DNA damage to mammalian cells by nitrofurans.Chem. Biol. Interact., 16, 223 (1977).

    Article  PubMed  CAS  Google Scholar 

  16. Osabeiki-Ebor, E. E., Akerele, J. O.: Nitrofuran mutagenicity; induction of frameshift mutations.Mutation Res., 175, 149 (1986).

    Article  Google Scholar 

  17. Rosenkranz, H. S., Speck, W. T.: Activation of nitrofurantoin to a mutagen by rat liver nitro-reductase.Biochem. Pharmacol., 25, 1555 (1976).

    Article  PubMed  CAS  Google Scholar 

  18. Rosenkranz, H. S., Speck, W. T.: Mutagenicity of metronidazole activation by mammalian liver microsomes.Biochem. Biophys. Res. Commun., 66, 520 (1975).

    Article  PubMed  CAS  Google Scholar 

  19. Sesame, H. A., Boyd, M. R.: Superoxide and hydrogen peroxide production and NADPH reduction stimulated by nitrofurantoin in lung microsomes: Possible implications for toxicity.Life Sci., 24, 1091 (1979).

    Article  Google Scholar 

  20. Wolf, S., Perry, P.: Differential Giemsa staining of SCE without autoradiography.Chromosoma (Berl.) 48, 341 (1974).

    Article  Google Scholar 

  21. Zampieri, A., Greenberg, J.: Nitrofurazone as a mutagen in E. coli.Biochem. Biophys. Res. Commun., 14, 172 (1964).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Toxicology, Faculty of Pharmacy, Gazi University, Ankara, Turkey

    S. Şardaş, A. Metin, S. Gök, A. E. Karakaya & N. Aykol

  2. Departments of Urology and Paediatry, TCD Ankara Hospital, Ankara, Turkey

    S. Şardaş, A. Metin, S. Gök, A. E. Karakaya & N. Aykol

Authors
  1. S. Şardaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Metin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Gök
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. E. Karakaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Aykol
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Şardaş, S., Metin, A., Gök, S. et al. Sister chromatid exchanges in peripheral lymphocytes of urinary tract infection treated with nitrofurantoin. International Urology and Nephrology 22, 513–517 (1990). https://doi.org/10.1007/BF02549738

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549738

Keywords

Search

Navigation